$GNCA GENOCEA BIOSCIENCES, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in GENOCEA BIOSCIENCES, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in GENOCEA BIOSCIENCES, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in GENOCEA BIOSCIENCES, INC. for free.

CIK Number: 0001457612
IRS Number: 510596811
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: GNCA
Company Address: 100 ACORN PARK DRIVE CAMBRIDGE 02140
Phone number: 617-876-8191
Former name: GENOCEA BIOSCIENCES INC, date of change: 2009-03-04

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.

Market Capitalization: $129.13M
Prev close: $4.51
Average Daily Volume: 198,748
Days Low: $4.45
Year Low: $2.65
Year High: $8.07

GENOCEA BIOSCIENCES, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Duvall DianthaCHIEF FINANCIAL OFF ...Option ExerciseA0.00100,0000100,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Duvall DianthaCHIEF FINANCIAL OFF ...Option ExerciseA3.01112,500338,625112,500
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Duvall DianthaCHIEF FINANCIAL OFF ...GrantA0.0037,500037,5000 to 37.5 K
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Clark William DPresident and CEOOption ExerciseA0.00600,0000600,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Clark William DPresident and CEOOption ExerciseA3.01450,0001,354,500450,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Clark William DPresident and CEOGrantA0.00150,0000150,0000 to 150 K
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Flechtner Jessica BakerChief Scientific Of ...Option ExerciseA0.00100,0000100,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Flechtner Jessica BakerChief Scientific Of ...Option ExerciseA3.01131,250395,063131,250
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Flechtner Jessica BakerChief Scientific Of ...GrantA0.0043,750043,7500 to 43.8 K
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Aakalu Girish NCHIEF BUSINESS OFFI ...Option ExerciseA0.00100,0000100,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Aakalu Girish NCHIEF BUSINESS OFFI ...Option ExerciseA0.00100,0000100,000
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Aakalu Girish NCHIEF BUSINESS OFFI ...Option ExerciseA3.0193,750282,18893,750
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Aakalu Girish NCHIEF BUSINESS OFFI ...Option ExerciseA3.0193,750282,18893,750
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Aakalu Girish NCHIEF BUSINESS OFFI ...GrantA0.0031,250031,2500 to 31.3 K
Mar 17 2021GNCAGENOCEA BIOSCIENCE ...Aakalu Girish NCHIEF BUSINESS OFFI ...GrantA0.0031,250031,2500 to 31.3 K

View all GENOCEA BIOSCIENCES, INC. insider transactions.